University of Eastern Piedmont at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
University of Eastern Piedmont brings 2 presentations to ESGCT 2026 in Hamburg. Its groups study gene therapy for bleeding disorders delivered by lentiviral vectors. The work targets the liver endothelium as a durable site for haemophilia gene transfer, and shows that factor VIII deficiency also affects blood vessel stability in the brain and bone health.
| Organization | ESGCT 2026 Attendance |
|---|---|
University of Eastern Piedmont Novara, Italy | |
Italian university with research on liver-directed lentiviral gene therapy for haemophilia. | Poster Thu Oct 29 2:00pm–4:00pm FVIII deficiency impairs cerebrovascular stability and bone homeostasis: rescue by endothelial‑targeted gene therapy by lentiviral vectors Talk Fri Oct 30 10:15am–10:30am Hepatic endothelium as a safe and durable target for lentiviral gene therapy of hemophilia Vectors and delivery (AAV, lentiviral, LNP)Rare and inherited disease |
Instantly find 20 buyers from University of Eastern Piedmont
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction